Biomarin Pharmaceutical Inc (BMRN) valuation · P/E 147, rev $3.22B
Biomarin Pharmaceutical Inc (BMRN) P/E 147, rev $3.22B.
| Metric | Value |
|---|---|
| P/E | 147 |
| Market cap | $10.63B |
| Revenue | $3.22B |
| P/S | 3.3 |
| P/B | 1.7 |
BMRN valuation FAQ
What is BMRN's P/E ratio?
Biomarin Pharmaceutical Inc (BMRN) trailing P/E is 147 on the latest cached fundamentals snapshot.
What is BMRN's market cap?
Biomarin Pharmaceutical Inc (BMRN) market cap is $10.63B on the latest cached fundamentals snapshot.
What is BMRN's latest revenue?
Latest cached Biomarin Pharmaceutical Inc (BMRN) revenue was $3.22B. Statements: https://lician.com/financials/bmrn
What is BMRN's price-to-sales ratio?
Biomarin Pharmaceutical Inc (BMRN) price-to-sales (P/S) is 3.3, cached market cap $10.63B divided by revenue $3.22B.
What is BMRN's price-to-book ratio?
Biomarin Pharmaceutical Inc (BMRN) price-to-book (P/B) is 1.7 on the latest cached fundamentals snapshot.
How many BMRN valuation scalars are listed on this page?
This page lists 5 cached valuation scalars for Biomarin Pharmaceutical Inc (BMRN): P/E, Market cap, Revenue, P/S, and P/B.
Where is BMRN valuation listed?
Cached valuation multiples for Biomarin Pharmaceutical Inc (BMRN) are listed at https://lician.com/valuation/bmrn.
Not investment advice. Cached rows, not a live tape.